Alpha Cognition elects Robert Wills as board chairman

Alpha Cognition has elected Robert Wills as its new board chairman, succeeding the retired Len Mertz. Wills, who has served on the board since 2025 and chairs the governance committee, is also chairman of Milestone Pharmaceuticals and a former Johnson & Johnson executive.

Alpha Cognition elected Robert Wills as chairman, replacing Len Mertz, who retired from the board. * Wills has served on the board since 2025, chairs the governance and nominating committee, sits on the audit committee. * He is chairman at Milestone Pharmaceuticals, previously chaired CymaBay Therapeutics before its March 2024 sale to Gilead Sciences. * Wills spent more than 25 years at Johnson & Johnson, including senior roles in alliance management at Janssen and global development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606230830BIZWIRE_USPR_____20260623_BW450250) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Alpha Cognition elected Robert Wills as chairman, replacing Len Mertz, who retired from the board. * Wills has served on the board since 2025, chairs the governance and nominating committee, sits on the audit committee. * He is chairman at Milestone Pharmaceuticals, previously chaired CymaBay Therapeutics before its March 2024 sale to Gilead Sciences. * Wills spent more than 25 years at Johnson & Johnson, including senior roles in alliance management at Janssen and global development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606230830BIZWIRE_USPR_____20260623_BW450250) on June 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)